Characterization of Influenza:Streptococcus pneumoniae synergistic disease and potential for disease alleviation via sphingolipid therapy
Influenza A virus (IAV) is generally associated with the seasonal malady that causes brief respiratory illness during the winter months, known simply as "the flu." Most otherwise healthy individuals will suffer from mild fever, congestion, headaches and myalgia that are resolved within 5-...
Main Author: | Gasser, Amanda Lynn |
---|---|
Other Authors: | Veterinary Medicine |
Format: | Others |
Published: |
Virginia Tech
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/10919/51569 |
Similar Items
-
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01) -
Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
by: Sabira Mohammed, et al.
Published: (2018-07-01) -
Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
by: Sabira Mohammed, et al.
Published: (2017-03-01) -
Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
by: Joanna A. Motyl, et al.
Published: (2021-06-01) -
FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury
by: Thomas V. Rousselle, et al.
Published: (2020-06-01)